Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.52 |
| ▸ | TYR | P14679 | 2/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.39 |
| ▸ | PTGFR | P43088 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.39 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.38 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.38 |
| ▸ | DAO | P14920 | 2/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15255040 | 0.88 | TAAR1 (0.48) | TAAR1TYRALDH1A1GAATSHR | |
| SCHEMBL9794663 | 0.87 | TAAR1 (0.56) | TAAR1SLC6A2SLC6A4SLC6A3ALDH1A1 | |
| SCHEMBL3047458 | 0.83 | TAAR1 (0.56) | TAAR1SLC6A2SLC6A4SLC6A3ALDH1A1 | |
| SCHEMBL1983016 | 0.82 | TAAR1 (0.55) | TAAR1SLC6A2SLC6A4SLC6A3ALDH1A1 | |
| SCHEMBL16265337 | 0.80 | TAAR1 (0.48) | TAAR1ALDH1A1GAATSHRPTGER1 | |
| SCHEMBL10937017 | 0.80 | TAAR1 (0.48) | TAAR1ALDH1A1PTGER1PTGFRKMT2A | |
| SCHEMBL15945059 | 0.79 | SLC6A4 (0.63) | TAAR1SLC6A2SLC6A4SLC6A3ALDH1A1 | |
| SCHEMBL2486648 | 0.79 | TYR (0.61) | TAAR1TYRSLC6A4TSHR | |
| SCHEMBL14286302 | 0.79 | TYR (0.47) | TYRSLC6A2SLC6A4SLC6A3ALDH1A1 | |
| SCHEMBL3652083 | 0.79 | TAAR1 (0.47) | TAAR1SLC6A2SLC6A4SLC6A3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10370767-B2 | Process for preparing alcohols by electrochemical reductive coupling | BASF SE (DE) | 2019-08-06 | — | — | US | claimed |
| US-9040592-B2 | Process for preparing 4-cyclohexyl-2-methyl-2-butanol | BASF SE (DE) | 2015-05-26 | — | — | US | claimed |
| EP-1716159-B1 | BICYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | MOMENTIVE PERFORMANCE MAT INC (US) | 2011-07-13 | — | — | EP | claimed |
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-9102665-B2 | Cysteinyl leukotriene antagonists | SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) | 2015-08-11 | — | — | US | disclosed |
| EP-2834233-A1 | NEW ALPHA2 ADRENOCEPTOR AGONISTS | Orion Corporation (FI) | 2015-02-11 | — | — | EP | disclosed |
| US-20140155596-A1 | CYSTEINYL LEUKOTRIENE ANTAGONISTS | SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) | 2014-06-05 | — | — | US | disclosed |
| WO-2013150173-A1 | NEW ALPHA2 ADRENOCEPTOR AGONISTS | ORION CORPORATION (FI) | 2013-10-10 | — | — | WO | disclosed |
| US-20020032132-A1 | Cyclic compounds and their use as precursors of fragrant alcohols | ANTARES CAPITAL CORPORATION, AS AGENT | 2002-03-14 | — | — | US | disclosed |
| US-20020016269-A1 | Particle perfume delivery system | THE PROCTER & GAMBLE CO. | 2002-02-07 | — | — | US | disclosed |
| US-6184188-B1 | LAUNDRY DETERGENT COMPRISING SPECIFIED BETA-KETO ESTER ?PRO-FRAGRANCES? SUCH AS 3,7-DIMETHYL-1,6-OCTADIEN-3-YL 1-(2-NAPHTHYL)-3-OXO-PROPIONATE, AND A DETERSIVE SURFACTANT, AND CARRIERS | THE PROCTER & GAMBLE COMPANY | 2001-02-06 | — | — | US | disclosed |
| EP-0287084-A2 | Alcohols containing 2-methyl or 2-methoxyphenyl groups, and their use as flavouring agents | Consortium für elektrochemische Industrie GmbH (DE) | 1988-10-19 | — | — | EP | disclosed |
| EP-0149976-A2 | Substituted imidazoles | CIBA-GEIGY AG (CH) | 1985-07-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | F9, RPL39, ECPAS | TAAR1 1368/4885TYR 2269/4885SLC6A2 4834/4885 |
| US-20140155596-A1 | CYSTEINYL LEUKOTRIENE ANTAGONISTS | LTC4S, CYSLTR2, CYSLTR1 | TAAR1 2187/4885TYR 2536/4885SLC6A2 3058/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.